© 1988 Oxford University Press
research-article |
Tissue distribution of covalent DNA damage in mice treated dermally with cigarette tar: preference for lung and heart DNA
Department of Pharmacology, Baylor College of Medicine Houston, TX 77030, USA
The high incidence of lung cancer in smokers is thought to be related to the direct exposure of bronchial and pulmonary cells to carcinogens in inhaled cigarette smoke. Using a 32P-postlabeling assay for chemically induced covalent DNA alterations, we found that unfractionated, relatively non-polar cigarette smoke components bound preferentially to lung and heart DNA in female ICR mice. After 6 days of topical treatment with cigarette smoke condensate (CSC) equivalent to a total of 4.5 cigarettes, covalent DNA damage was estimated to be 6.2, 5.7, 3.9 and 1.9 times higher, respectively, in lung, heart, skin and kidney than in liver, ranging from approximately 1 adduct in 5.4 ± 0.7 x 106 DNA nucleotides in lung to 1 adduct in 3.3 ± 0.6 x 107 DNA nucleotides in liver. Spleen DNA was virtually adduct-free. Adducts occupied two extensive zones, designated diagonal radioactive zone (DRZ) 1 and DRZ 2, on TLC fingerprints. Preference for lung and heart DNA was also observed in mice treated for 1 or 3 days. An inverse association appeared to exist between the tissue distribution of CSC-induced covalent DNA damage and the reported activity of enzymes catalyzing the metabolism of xenobiotlcs (cytochrome P-450 monooxygenases, phase II enzymes) and toxic oxygen species (superoxide dismutase, catalase). The results suggest that the well-known pulmonary and cardiovascular organotropism of cigarette-smoking-associated adverse health effects may, in part, have its origin in the inherent capacity of cigarette smoke components to induce lesions in lung and heart DNA in a tissue-specific manner. Possible mechanisms and health implications of the preferential binding of presumably aromatic CSC constituents to lung and heart DNA are discussed.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M C Cornelis, A El-Sohemy, and H Campos Genetic polymorphism of CYP1A2 increases the risk of myocardial infarction J. Med. Genet., October 1, 2004; 41(10): 758 - 762. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Thapliyal, S. S. Dolas, S. S. Pakhale, and G. B. Maru Evaluation of DNA damage in mice topically exposed to total particulate matter from mainstream and sidestream smoke from cigarettes and bidis Mutagenesis, September 1, 2004; 19(5): 413 - 421. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Van schooten, A. Hirvonen, L. M. Maas, B. A. De mol, J. C. S. kleinjans, D. A. Bell, and J. D. Durrer Putative susceptibility markers of coronary artery disease: association between VDR genotype, smoking, and aromatic DNA adduct levels in human right atrial tissue FASEB J, October 1, 1998; 12(13): 1409 - 1417. [Abstract] [Full Text] |
||||
![]() |
A. Izzotti, R. M. Balansky, P. M. Blagoeva, Z. I. Mircheva, L. Tulimiero, C. Cartiglia, and S. D. Flora DNA alterations in rat organs after chronic exposure to cigarette smoke and/or ethanol ingestion FASEB J, June 1, 1998; 12(9): 753 - 758. [Abstract] [Full Text] |
||||
![]() |
G. Scherer and E. Richter Biomonitoring exposure to environmental tobacco smoke (ETS): A critical reappraisal Human and Experimental Toxicology, August 1, 1997; 16(8): 449 - 459. [Abstract] [PDF] |
||||



